Search
  • Search

    REQUEST FOR INFORMATION: ddPCR Instrument

    HUS-yhtymä

    REQUEST FOR INFORMATION: ddPCR Instrument

    1. Planning notice published

      Mar 3, 12:49 PMMarch 3, 2026 12:49 PM

    2. Planned competition start

      May 29, 12:00 AMMay 29, 2026 12:00 AM

    Brief

    Finland: Tenders/HUS-yhtymä/REQUEST FOR INFORMATION: ddPCR Instrument

    Published deadline passed

    The published deadline has passed. For multi-stage competitions a later tender deadline may still apply — check the notice or portal for the current phase.

    Brief

    Laboratorie-kits og reagenser

    HUS-yhtymä is planning the procurement of ddPCR instruments for their Laboratory of Genetics, which performs approximately 3,500 analyses per year using the ddPCR method. Suppliers are requested to provide information on their ddPCR instruments, including technology, performance, workflow, capacity, automation, validation, references, instrument configuration, software, data management, maintenance, support, and cost estimates, by email to kilpailutus.diagnostiikka@hus.fi.

    About the bid

      With this request for information, HUS launches a market consultation to prepare a procurement. The aim of this prior information notice is to find suppliers operating in this field of business, get information of the solutions available in the market, and inform our plans and requirements for the forthcoming procurement. DESCRIPTION OF THE SUBJECT OF THE REQUEST FOR INFORMATION HUS Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is a SFS-EN ISO 15189:2022 accredited laboratory providing diagnostic and follow-up genetic testing services to all patients at Helsinki University Hospital area. The genetics laboratory performs approximately 3 500 analyses per year using the ddPCR method, and the number is continuously increasing. This Request for Information is released for preliminary evaluation and market research for potential ddPCR instrument suppliers. INSTRUCTIONS FOR ANSWERING Responses to this request for information must be submitted by email to kilpailutus.diagnostiikka@hus.fi no later than 18 March 2026. The subject line of the email must include: HUS 091-2026 ddPCR Instrument. The response must include all the information requested below in sections 1–7. The respondent is also requested to provide a contact person and an email address for any potential subsequent one-to-one market dialogue and/or additional information requests from the contracting authority. Respondents may also attach any available brochures related to the proposed products or services. Requirements to be addressed in the RFI Response: 1. Technology and Performance 1.1 What technology is the instrument based on (Droplet vs. Chip)? 1.2 Does the instrument support multiplexing? How many fluorescence channels are available? 1.3 Performance across different sample types (cell-free, whole blood, FFPE, bone marrow), including examples of analytical accuracy, sensitivity, and limits of detection. 1.4 How are detection limits determined for different sample matrices? 1.5 What types of analyses can be performed on the instrument? Examples: copy number analysis, genotyping, expression analysis, LOH, methylation. 2. Workflow, Capacity and Automation 2.1 Turnaround times for the instrument (including manual pipetting steps). 2.2 Instrument capacity: How many samples can be processed simultaneously? 2.3 Is droplet or chip generation automated? 3. Validation and References 3.1 Available validation data. 3.2 User references. 4. Instrument Configuration 4.1 Complete list of required components. 4.2 Reagents and mutation kits: Are they instrument specific or compatible with open systems? 4.3 Available kit sizes. 4.4 Availability of ready-to-use controls for assays. 4.5 Consumables: Are they instrument specific or compatible with open systems? 4.6 Availability and supply reliability. 4.7 CE-IVD marking. 5. Software and Data Management 5.1 Required software. 5.2 Required IT systems for instrument operation and data analysis. Are these included in the total price? 5.3 How is the analysis performed? 5.4 To what extent can raw data be processed by the user? 5.5 Can data be transferred to a LIMS system? 5.6 Supported file formats. 6. Maintenance and Support 6.1 Availability of local technical support. 6.2 Installation and training. Is a separate validation package available for the instrument? 7. Cost Estimate 7.1 Estimated costs for the instrument, maintenance, and consumables.

      Contact name
      Diagnostiikka
      Contact phone
      +358 94711
      Contact email
      kilpailutus.diagnostiikka@hus.fi
      Address
      Uutistie 5, 01770 Vantaa

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

      Found no award criteria in the contract notice.

    Qualification requirements

      Found no qualification requirements in the contract notice.

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    HUS-yhtymä
    Title
    REQUEST FOR INFORMATION: ddPCR Instrument
    Type
    Planning
    Main code
    38000000Laboratory, optical and precision equipments (excl. glasses)
    Supplemental codes
    33000000Medical equipments, pharmaceuticals and personal care products38950000Polymerase Chain Reaction (PCR) equipment38951000Real-time Polymerase Chain Reaction (PCR) equipment
    Location
    Helsinki-Uusimaa

    Active similar competitions

    • HUS-yhtymä

      Medisinsk og laboratorieutstyr

      REQUEST FOR INFORMATION: SPRI Beads

      HUS-yhtymä is planning the procurement of DNA size selection reagents based on paramagnetic beads, utilizing SPRI technology for selective binding and purification of DNA fragments, to be used in next-generation sequencing (NGS) library preparation. Suppliers can provide feedback and input by submitting a response via email to kilpailutus.diagnostiikka@hus.fi, addressing all requirements, providing requested information and documentation, and identifying any concerns or proposed amendments to the draft agreement.

      PlanningAug 18, 2026
      Nov 1, 2026(3 days)

    • HUS-yhtymä

      Laboratorie-kits og reagenser

      Automaattinen nukleiinihappojen eristyslaite

      HUS-yhtymä suunnittelee automaattisen nukleiinihappojen eristyslaitteen hankintaa HUS Diagnostiikkakeskuksen Kliinisen mikrobiologian nukleiinihappoanalytiikkaan, sisältäen laitteen, varalaitteen tai kaksi erillistä eristysmoduulia sekä tarvittavat reagenssit ja tarvikkeet. Hankittavalla laitteella on tarkoitus eristää bakteeri-DNA:ta useista eri näytemateriaaleista, ja eristetyn tuotteen tulee olla validoitu bakteerien 16S-geenin PCR-monistamiseen Sanger-sekvensoinnilla. Toimittajia pyydetään tutustumaan liitteenä oleviin kysymyksiin ja toimittamaan vastaukset sähköpostitse osoitteeseen kilpailutus.diagnostiikka@hus.fi. bioMérieux Suomi OY:llä on todennäköisesti sopimus tällä hetkellä.

      PlanningSep 16, 2026
      Jan 16, 2027(79 days)

    • HUS-yhtymä

      Engroshandel med medisinske og husholdningsvarer

      Tietopyyntö: Perusterveydenhuollon näytteenottotarvikkeet 2

      HUS-yhtymä kartoittaa markkinoita tulevaa perusterveydenhuollon näytteenottotarvikkeiden hankintaa varten; hankintaan kuuluvat vakuumiputket, turvaneulat sekä erikoisputket likvorin näytteenottoon ja NIPT-seulontaan. Toimittajat voivat osallistua suunnitteluun ilmoittautumalla tietopyyntöön ja kuvaamalla tuotevalikoimansa sekä tuotteiden vastuullisuutta, kuten pakkausten kierrätettävyyttä ja valmistuksen eettisyyttä ja ympäristöystävällisyyttä; mukaan voi liittää esitteitä, ja HUS saattaa ehdottaa vastaajille tarkentavia markkinavuoropuheluja. Hankinta suunnitellaan toteutettavaksi HUSin ja muiden hyvinvointialueiden yhteishankintana.

      PlanningOct 23, 2026
      Feb 23, 2027(117 days)

    • Sansia Oy

      Medisinsk og laboratorieutstyr

      TIETOPYYNTÖ Mikrobiologian nukleiinihappo-osoitusmenetelmät, ISLAB

      Sansia Oy suunnittelee mikrobiologian nukleiinihappo-osoitusmenetelmien hankintaa ja pyytää toimittajilta tietoa ja kommentteja markkinakartoitusta varten. Toimittajat voivat antaa palautetta tutustumalla liitteeseen "Saate tietopyyntöön", täydentämällä liitteen "Tietopyynnön kysymykset" ja lataamalla muita kommentteja sekä tuote-esitteitä.

      PlanningOct 8, 2026
      Oct 30, 2026(1 day)

    • HUS-yhtymä

      REQUEST FOR INFORMATION: HUS 364-2026 Osseointegrated implant systems

      HUS Group is planning the procurement of osseointegrated implant systems for patients with upper and/or lower limb loss, including intramedullary osseointegrated implants, fixation components, prosthetic attachment systems, surgical instruments, and related digital solutions and services. Suppliers are invited to provide information on their products, clinical evidence, regulatory compliance, and support services by submitting responses electronically to kilpailutus.kirurgia@hus.fi. HUS procurement may also invite selected suppliers to participate in a market dialogue meeting via Microsoft Teams to gather further information.

      PlanningAug 13, 2026
      Dec 13, 2026(45 days)